TABLE 1.
Distribution of genetic subtypes in protease and RT regions of 142 treatment-naive patients
| Originating country | No. of strains
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Group M nonrecombinant forms
|
Group M recombinant forms
|
Group O | ||||||||||||||||
| A | B | C | D | F1 | F2 | G | J | K | CRF02-AG | CRF01-AE | A/G | G/A/G | G/K | D/G/D | ?/K | Ua | |||
| Cameroon | 62 | 6 | 3 | 9 | 3 | 3 | 1 | 34 | 1 | 1 | 1 | ||||||||
| Senegal | 38 | 2 | 4 | 1 | 1 | 1 | 23 | 1 | 1 | 1 | 3 | ||||||||
| DRC | 18 | 1 | 1 | 4 | 6 | 2 | 2 | 2 | |||||||||||
| France | 24 | 1 | 9 | 1 | 1 | 2 | 1 | 6 | 2 | 1 | |||||||||
| Total | 142 | 9 | 13 | 2 | 5 | 2 | 9 | 4 | 5 | 2 | 67 | 3 | 6 | 2 | 2 | 1 | 4 | 2 | 4 |
U, did not cluster with any of the known subtypes.